Stay updated on GB5121 in Refractory CNS Lymphoma Clinical Trial
Sign up to get notified when there's something new on the GB5121 in Refractory CNS Lymphoma Clinical Trial page.

Latest updates to the GB5121 in Refractory CNS Lymphoma Clinical Trial page
- CheckyesterdayChange DetectedThe page shows an updated revision tag: Revision: v3.5.2, replacing Revision: v3.5.0.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedRevision history updated to add Revision: v3.5.0 and remove Revision: v3.4.3.SummaryDifference0.1%

- Check36 days agoChange Detected- Revision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.1%

- Check65 days agoChange DetectedA new Revision: v3.4.2 appears, and the prior operating-status notice regarding government funding has been removed; these changes are administrative and do not alter the study information.SummaryDifference0.4%

- Check72 days agoChange DetectedA government funding lapse notice was added, informing users that the NIH Clinical Center is open and directing users to cc.nih.gov and opm.gov for status updates. The page version was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check79 days agoChange DetectedChanges include adding Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, and removing Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to GB5121 in Refractory CNS Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GB5121 in Refractory CNS Lymphoma Clinical Trial page.